NOT-CA-17-047: Notice of Change to PA-17-243, "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)"

Notice of Change to PA-17-243 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)"

Notice Number: NOT-CA-17-047

Key Dates
Release Date: April 7, 2017

Related Announcements
PA-17-243

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to add to PA-17-243 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)". The following "Data sharing" subsection (in italics) has been added, before the "Collaborations and authorship" subsection.

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Currently reads

Collaborations and authorship
Projects developed in response to this FOA should include expertise such as cancer epidemiology, omics, biostatistics, bioinformatics, and/or computational biology.
Any publications resulting from awards funded under this FOA must include acknowledgment of the source of shared data and any funding sources which supported the initial data collection.

Modified to read
Data sharing

Applicants are encouraged to make publicly available the cleaned and harmonized datasets, software and programmed codes developed for the secondary analysis and integration of the data, when appropriate, and consistent with participant informed consent. Sharing of adequate documentation and explanation is also encouraged so that data and tools can be used by researchers not associated with the original study.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Melissa Rotunno, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7245
Email: [email protected]